The European Patent Office (EPO) has published patent application EP4178503A1, titled "Blood Flow Modification Device and Methods of Using the Same." The application was filed by Anaxiom Corporation and includes inventors Justin Jerome Ringhofer, William E. Cohn, and Nick Gentile. The publication date is March 11, 2026, and it covers various International Patent Classifications related to medical devices and surgical instruments.

This publication represents the granting of intellectual property rights for a novel medical device. While not a regulatory rule imposing compliance obligations, it signifies a new innovation in the prosthetics and medical device sector. Companies operating in this space, particularly those manufacturing or developing similar technologies within the designated states (including AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), should be aware of this patent for potential licensing or competitive analysis purposes.